Tip:
Highlight text to annotate it
X
>> HELLO, I AM ALLEN FISHER ON "AZ ILLUSTRATED SCIENCE" LINKS
"AZ ILLUSTRATED SCIENCE" LINKS BETWEEN COMPASSION AND
BETWEEN COMPASSION AND INFLAMMATION.
INFLAMMATION. THOUGHT PROVOKING IMAGES OF
THOUGHT PROVOKING IMAGES OF CANCER CELLS MAY PROVIDE INSIGHT
CANCER CELLS MAY PROVIDE INSIGHT INTO CANCER TREATMENT.
INTO CANCER TREATMENT. THE ARIZONA LEGISLATURE
THE ARIZONA LEGISLATURE CONTINUES WRESTLING WITH THE
CONTINUES WRESTLING WITH THE STATE BUDGET FOR THE NEXT FISCAL
STATE BUDGET FOR THE NEXT FISCAL YEAR.
YEAR. THE HOUSE OF REPRESENTATIVES IS
THE HOUSE OF REPRESENTATIVES IS WORKING TO FIGURE OUT AN
WORKING TO FIGURE OUT AN APPROACH AFTER A GROUP OF
APPROACH AFTER A GROUP OF MODERATE REPUBLICANS STRUCK A
MODERATE REPUBLICANS STRUCK A DEAL WITH HOUSE SPEAKER ANDY
DEAL WITH HOUSE SPEAKER ANDY TOBIN LATE MONDAY DESCRIBED AS
TOBIN LATE MONDAY DESCRIBED AS TEN WAS.
TEN WAS. MIDDAY TODAY, TALKS WERE BACK ON
MIDDAY TODAY, TALKS WERE BACK ON AS HOUSE LEADERS TRIED TO GET
AS HOUSE LEADERS TRIED TO GET ENOUGH VOTES TO PASS THE PLAN.
ENOUGH VOTES TO PASS THE PLAN. GOVERNOR JAN BREWER WILL HAVE
GOVERNOR JAN BREWER WILL HAVE FINAL SAY ON WHATEVER BUDGET
FINAL SAY ON WHATEVER BUDGET PLAN LAW MAKERS PASS.
PLAN LAW MAKERS PASS. HER OFFICE HAS NOT ISSUED A
HER OFFICE HAS NOT ISSUED A STATEMENT ABOUT THE HOUSE
STATEMENT ABOUT THE HOUSE BUDGET.
BUDGET. OFFICIALS SAY THERE ARE STILL A
OFFICIALS SAY THERE ARE STILL A DOZENER U EISSUES THE GOVERNOR
DOZENER U EISSUES THE GOVERNOR TO SEE ADDRESSED.
TO SEE ADDRESSED. THE HOUSE PLAN DOES NOT TAKE
THE HOUSE PLAN DOES NOT TAKE CARE OF THEM.
CARE OF THEM. THE STATE SENATE APPROPRIATIONS
THE STATE SENATE APPROPRIATIONS COMMITTEE, APPROVED A PROPOSAL
COMMITTEE, APPROVED A PROPOSAL AUTHORIZING AIRS HAIRS TO BUILD
AUTHORIZING AIRS HAIRS TO BUILD A VIRTUAL FENCE ALONG THE BORDER
A VIRTUAL FENCE ALONG THE BORDER WITH MEXICO.
WITH MEXICO. THE BILL ALLOWS THE STATE TO PUT
THE BILL ALLOWS THE STATE TO PUT UP 300 TOWERS WITH RADAR AND
UP 300 TOWERS WITH RADAR AND CAMERAS ALONG THE BORDER.
CAMERAS ALONG THE BORDER. THE U.S. GOVERNMENT TRIED A
THE U.S. GOVERNMENT TRIED A SIMILAR PROGRAM BUT SCRAPPED IT
SIMILAR PROGRAM BUT SCRAPPED IT AFTER SPENDING $1 BILLION A FEW
AFTER SPENDING $1 BILLION A FEW YEARS AGO.
YEARS AGO. SUPPORTERS OF ARIZONA'S PROJECT
SUPPORTERS OF ARIZONA'S PROJECT SAY THEY COULD DO IT FOR $30
SAY THEY COULD DO IT FOR $30 MILLION.
MILLION. THE PROPOSAL APPROVED IN THE
THE PROPOSAL APPROVED IN THE SENATE HAS NO MONEY TIED TO IT.
SENATE HAS NO MONEY TIED TO IT. THE SENATE APPROPRIATIONS
THE SENATE APPROPRIATIONS COMMITTEE ALSO APPROVED A BILL
COMMITTEE ALSO APPROVED A BILL MAKING IT MORE DIFFICULT FOR
MAKING IT MORE DIFFICULT FOR PUBLIC SCHOOL DISTRICTS TO
PUBLIC SCHOOL DISTRICTS TO CONVERT SOME SCHOOLS TO
CONVERT SOME SCHOOLS TO CHARTERS.
CHARTERS. THAT IDEA IS ONE OF THE MAJOR
THAT IDEA IS ONE OF THE MAJOR STUMBLING BLOCKS FOR HOUSE
STUMBLING BLOCKS FOR HOUSE BUDGET NEGOTIATORS.
BUDGET NEGOTIATORS. SENATE PRESIDENT ANDY BIGGS
SENATE PRESIDENT ANDY BIGGS SUPPORTS THE PLAN SAYING CHARTER
SUPPORTS THE PLAN SAYING CHARTER SCHOOLS ARE DRAINING MONEY FROM
SCHOOLS ARE DRAINING MONEY FROM OTHER PUBLIC SCHOOLS.
OTHER PUBLIC SCHOOLS. AND THAT IS A LOOK AT TONIGHT'S
AND THAT IS A LOOK AT TONIGHT'S HEADLINES.
HEADLINES. >> HOW COMPASSIONATE ARE YOU?
>> HOW COMPASSIONATE ARE YOU? NOT JUST METAPHYSICAL.
NOT JUST METAPHYSICAL. SCIENTISTS FOUND LINK BETWEEN
SCIENTISTS FOUND LINK BETWEEN COMPASSION, DEPRESSION AND
COMPASSION, DEPRESSION AND INFLAMMATION.
INFLAMMATION. THIS MONTH WE ARE FEATURING A
THIS MONTH WE ARE FEATURING A NUMBER OF RESEARCH PROJECTS
NUMBER OF RESEARCH PROJECTS STUDYING INFLAMMATION.
STUDYING INFLAMMATION. WE BEGIN ATTENDING A WEEKEND
WE BEGIN ATTENDING A WEEKEND LONG EVENT, CALLED COGNITIVELY
LONG EVENT, CALLED COGNITIVELY BASED COMPASSION TRAINING.
BASED COMPASSION TRAINING. >> MAY I CHERISH ALL THINGS MORE
>> MAY I CHERISH ALL THINGS MORE PRECIOUS.
PRECIOUS. >> ONE OF THE MAIN THINGS FOR ME
>> ONE OF THE MAIN THINGS FOR ME WAS DIRECTING COMPASSION TOWARD
WAS DIRECTING COMPASSION TOWARD MYSELF.
MYSELF. AND I THINK THAT IS A BIG
AND I THINK THAT IS A BIG CHALLENGE FOR A LOT OF PEOPLE.
CHALLENGE FOR A LOT OF PEOPLE. WE TEND TO BE VERY KIND TO
WE TEND TO BE VERY KIND TO OTHERS.
OTHERS. BUT, MEANWHILE WE CAN BE VERY,
BUT, MEANWHILE WE CAN BE VERY, VERY CRITICAL AND NEGATIVE
VERY CRITICAL AND NEGATIVE TOWARD OURSELVES.
TOWARD OURSELVES. INSIDE.
INSIDE. >> WE ARE ALL TRYING TO SURVIVE.
>> WE ARE ALL TRYING TO SURVIVE. TO, TO BE WELL.
TO, TO BE WELL. >> A STUDENT OF COMPASSION.
>> A STUDENT OF COMPASSION. SEEKING IT IN HER LIFE FOR
SEEKING IT IN HER LIFE FOR HERSELF AND OTHERS.
HERSELF AND OTHERS. THAT'S WHY SHE AND NEARLY 70
THAT'S WHY SHE AND NEARLY 70 OTHER PEOPLE TOOK PART IN A
OTHER PEOPLE TOOK PART IN A THREE-DAY COMPASSION TRAINING
THREE-DAY COMPASSION TRAINING RECENTLY IN TUCSON.
RECENTLY IN TUCSON. >> I AM REALLY EXCITED ABOUT
>> I AM REALLY EXCITED ABOUT COMPASSION.
COMPASSION. SORT OF FUNDAMENTAL TO ALL
SORT OF FUNDAMENTAL TO ALL ETHICAL SYSTEMS AND RELIGIOUS
ETHICAL SYSTEMS AND RELIGIOUS SYSTEM THOUSANDS.
SYSTEM THOUSANDS. AND IT JUST SEEMS LIKE A VERY
AND IT JUST SEEMS LIKE A VERY GENERIC PROCESS.
GENERIC PROCESS. SUCK TH
SUCK TH SOMETHING THAT WE ALL SHARE.
SOMETHING THAT WE ALL SHARE. >> IN ORDER TO ENHANCE ABILITY,
>> IN ORDER TO ENHANCE ABILITY, QUALITY TO BE PRESENT.
QUALITY TO BE PRESENT. WE NEED TO BE ABLE TO SUSTAIN
WE NEED TO BE ABLE TO SUSTAIN OUR AWARENESS.
OUR AWARENESS. >> THE GROUP WAS UNDER THE
>> THE GROUP WAS UNDER THE DIRECTION OF A FORMER TIBETAN
DIRECTION OF A FORMER TIBETAN BUDDHIST MONK AND THE FOUNDER OF
BUDDHIST MONK AND THE FOUNDER OF COGNITIVELY BASED COMPASSION
COGNITIVELY BASED COMPASSION TRAINING.
TRAINING. >> COMPASSION I THINK IS REALLY
>> COMPASSION I THINK IS REALLY WHEN YOU THING OF IT AS SOCIAL
WHEN YOU THING OF IT AS SOCIAL ANIMAL.
ANIMAL. AS WE ARE.
AS WE ARE. THAT IS A GLUE FOR -- SOCIETY TO
THAT IS A GLUE FOR -- SOCIETY TO KIND OF -- TO COME TOGETHER.
KIND OF -- TO COME TOGETHER. AND WHEN SOCIETY IS IN HARMONY
AND WHEN SOCIETY IS IN HARMONY AND -- AND -- YOU KNOW, IN THAT
AND -- AND -- YOU KNOW, IN THAT KIND OF -- POSITIVE STATE.
KIND OF -- POSITIVE STATE. THAT'S WHERE THE INDIVIDUAL AND
THAT'S WHERE THE INDIVIDUAL AND THE MEMBERS OF SOCIETY THEY
THE MEMBERS OF SOCIETY THEY FLOURISH.
FLOURISH. HEALTH AND WELL BEING AND
HEALTH AND WELL BEING AND HAPPINESS.
HAPPINESS. >> CULTIVATE WAYS IN WHICH WE
>> CULTIVATE WAYS IN WHICH WE CAN RELATE TO PEOPLE,
CAN RELATE TO PEOPLE, SITUATIONS, THINGS.
SITUATIONS, THINGS. IN WAYS THAT DON'T NEED TO DO,
IN WAYS THAT DON'T NEED TO DO, DESTRUCTIVE EMOTIONS.
DESTRUCTIVE EMOTIONS. >> THE TRAINING FOR IT IS A
>> THE TRAINING FOR IT IS A SECULAR TECHNIQUE THAT DRAWS
SECULAR TECHNIQUE THAT DRAWS FROM A MIND TRAINING PRACTICE IN
FROM A MIND TRAINING PRACTICE IN TIBET AND BUDDHISM.
TIBET AND BUDDHISM. LAUNCHED IN 2005.
LAUNCHED IN 2005. RESEARCH DESIGNED WHETHER IT
RESEARCH DESIGNED WHETHER IT COULD BE USED TO HELP COLLEGE
COULD BE USED TO HELP COLLEGE STUDENTS FIGHT DEPRESSION AND
STUDENTS FIGHT DEPRESSION AND STRESS.
STRESS. THE DATA CONFIRMED THE PRACTICE
THE DATA CONFIRMED THE PRACTICE OF SUCH TRAINING COULD IMPROVE
OF SUCH TRAINING COULD IMPROVE EMOTIONAL AND PHYSICAL RESPONSES
EMOTIONAL AND PHYSICAL RESPONSES TO STRESS.
TO STRESS. >> SO WE STARTED WONDERING IF WE
>> SO WE STARTED WONDERING IF WE DISCOVERED SOME WAY TO RETRAIN
DISCOVERED SOME WAY TO RETRAIN HOW PEOPLE WORK AT THEIR SOCIAL
HOW PEOPLE WORK AT THEIR SOCIAL SURROUNDINGS.
SURROUNDINGS. INSTEAD OF SEEING THE WORLD AS
INSTEAD OF SEEING THE WORLD AS A -- A DOMAIN OF THREAT AND
A -- A DOMAIN OF THREAT AND COMPETITION, THEY MIGHT SEE IT
COMPETITION, THEY MIGHT SEE IT AS A, AS AN ARENA FOR CARING AND
AS A, AS AN ARENA FOR CARING AND COOPERATION.
COOPERATION. A PSYCHIATRIST AND PARTNER IN
A PSYCHIATRIST AND PARTNER IN TRAINING, STUDIES, AND CHANGES.
TRAINING, STUDIES, AND CHANGES. >> OVER 20 YEARS.
>> OVER 20 YEARS. MORE AND MORE EVIDENCE.
MORE AND MORE EVIDENCE. THE IF MINE SYSTEM ALMOST A
THE IF MINE SYSTEM ALMOST A SECOND BRAIN.
SECOND BRAIN. WHAT THE IMMUNE SYSTEM DOES IN
WHAT THE IMMUNE SYSTEM DOES IN THE BODY IS ABLE TO SEND SIGNALS
THE BODY IS ABLE TO SEND SIGNALS TO YOUR BRAIN TO CHANGE HOW YOU
TO YOUR BRAIN TO CHANGE HOW YOU THINK, FEEL, CHANGE HOW YOU ACT.
THINK, FEEL, CHANGE HOW YOU ACT. SO WE BEGIN TO REALIZE THAT,
SO WE BEGIN TO REALIZE THAT, JUST AS THE THE INFLAMMATION CAN
JUST AS THE THE INFLAMMATION CAN MAKE PEOPLE FEEL DEPRESSED AND
MAKE PEOPLE FEEL DEPRESSED AND ISOLATED, PEOPLE WITH A LOT OF
ISOLATED, PEOPLE WITH A LOT OF STRESS, PEOPLE WHO FELT
STRESS, PEOPLE WHO FELT ISOLATED.
ISOLATED. UPSET, ANGRY, THEY GET THIS
UPSET, ANGRY, THEY GET THIS INCREASED INFLAMMATION WHICH IS
INCREASED INFLAMMATION WHICH IS GOING TO CAUSE THEM HEART
GOING TO CAUSE THEM HEART ATTACKS, STROKES, CANCER, AND
ATTACKS, STROKES, CANCER, AND DIF M
DIF M DIMENTIA AND MORE.
DIMENTIA AND MORE. AWE OFF
AWE OFF IT BROUGHT TOGETHER.
IT BROUGHT TOGETHER. STUDENTS.
STUDENTS. PRACTITIONERS OF MEDITATION.
PRACTITIONERS OF MEDITATION. SOME SUCH AS THIS WOMAN CAME
SOME SUCH AS THIS WOMAN CAME WITH A GOAL IN MIND.
WITH A GOAL IN MIND. >> I AM HERE, PERSONAL AND
>> I AM HERE, PERSONAL AND PROFESSIONAL.
PROFESSIONAL. I HAVE BEEN INTERESTED IN
I HAVE BEEN INTERESTED IN MINDFULNESS TRAINING FOR A LONG
MINDFULNESS TRAINING FOR A LONG TIME.
TIME. AND FRIED TO DEVTRIED TO DEVELO
AND FRIED TO DEVTRIED TO DEVELO PRACTICE.
PRACTICE. WAS PARTIALLY SUCCESSFUL.
WAS PARTIALLY SUCCESSFUL. FELT LIKE I WANTED TRAINING IN
FELT LIKE I WANTED TRAINING IN IT.
IT. FOR, FOR MY OWN PRACTICE AT
FOR, FOR MY OWN PRACTICE AT HOME.
HOME. BUT ALSO INTERESTED TIN IT
BUT ALSO INTERESTED TIN IT PROFESSIONALLY.
PROFESSIONALLY. SWITCHING CAREERS FROM BEING A
SWITCHING CAREERS FROM BEING A STUDIO ART, AND GETTING A DEGREE
STUDIO ART, AND GETTING A DEGREE IN EXPRESSIVE ARTS THERAPY.
IN EXPRESSIVE ARTS THERAPY. >> CONNECT WITH THE FEELING
>> CONNECT WITH THE FEELING HERE.
HERE. OF COMFORT AND JOY.
OF COMFORT AND JOY. A SENSE OF BEING SECURE THAT YOU
A SENSE OF BEING SECURE THAT YOU FEEL.
FEEL. >> IN THIS TRAINING WHAT PEOPLE
>> IN THIS TRAINING WHAT PEOPLE WILL GET IS -- IS A LOGIC IF YOU
WILL GET IS -- IS A LOGIC IF YOU WILL, UNDERLYING A PROCESS FOR
WILL, UNDERLYING A PROCESS FOR CULTIVATING MINDFULNESS.
CULTIVATING MINDFULNESS. HOW DO WE DEVELOP COMPASSION.
HOW DO WE DEVELOP COMPASSION. WHAT ARE THE KEY ELEMENTS OR THE
WHAT ARE THE KEY ELEMENTS OR THE KEY INGREDIENTS FOR CULTIVATING
KEY INGREDIENTS FOR CULTIVATING COMPASSION.
COMPASSION. AND HOW TO GO ABOUT ENHANCING
AND HOW TO GO ABOUT ENHANCING THOSE SPECIFIC INGREDIENTS.
THOSE SPECIFIC INGREDIENTS. SPECIFIC SKILLS.
SPECIFIC SKILLS. >> HE SAYS THE ELEMENTS OF THE
>> HE SAYS THE ELEMENTS OF THE TRAINING INCLUDE REGULATING
TRAINING INCLUDE REGULATING EMOTIONS AND DEVELOPING
EMOTIONS AND DEVELOPING AWARENESS OF ONE'S OWN EMOTIONS,
AWARENESS OF ONE'S OWN EMOTIONS, THOUGHTS AND UNDERLYING
THOUGHTS AND UNDERLYING ASSUMPTIONS.
ASSUMPTIONS. HE ADDS THAT PRACTICING
HE ADDS THAT PRACTICING COMPASSION IS ALSO ABOUT
COMPASSION IS ALSO ABOUT EXPENDING THIS -- EXPANDING THIS
EXPENDING THIS -- EXPANDING THIS TECHNIQUE TO STRANGERS AND PAEM
TECHNIQUE TO STRANGERS AND PAEM PAEM
PAEM -- PEOPLE WE DON'T CARE FOR.
-- PEOPLE WE DON'T CARE FOR. SHE HAS BEEN INTERESTED IN
SHE HAS BEEN INTERESTED IN COMPASSION TRAINING FOR A LONG
COMPASSION TRAINING FOR A LONG TIME.
TIME. SHE SAYS, WITH SUCH TRAINING SHE
SHE SAYS, WITH SUCH TRAINING SHE WANTS TO BECOME MORE
WANTS TO BECOME MORE COMPASSIONATE TOWARD HERSELF AND
COMPASSIONATE TOWARD HERSELF AND OTHERS.
OTHERS. ALL OF THE MEDITATION, AND
ALL OF THE MEDITATION, AND COMPASSION TRAINING THAT I HAVE
COMPASSION TRAINING THAT I HAVE DONE IS A MATTER OF JUST OPENING
DONE IS A MATTER OF JUST OPENING THE HEART.
THE HEART. AND SO BEING ABLE TO, TO CONNECT
AND SO BEING ABLE TO, TO CONNECT WITH PEOPLE.
WITH PEOPLE. IN A MORE -- PRESENT WAY.
IN A MORE -- PRESENT WAY. IT IS LESS ABOUT WHAT I AM
IT IS LESS ABOUT WHAT I AM THINKING ABOUT THEM AND MORE
THINKING ABOUT THEM AND MORE ABOUT, JUST, JUST CONNECTING IN
ABOUT, JUST, JUST CONNECTING IN THE HEART.
THE HEART. >> MANY OF US THAT ARE
>> MANY OF US THAT ARE INTERESTED IN -- IN SORT OF
INTERESTED IN -- IN SORT OF THINKING ABOUT HOW TO LIVE, YOU
THINKING ABOUT HOW TO LIVE, YOU KNOW, A MORE HUMAN LIFE.
KNOW, A MORE HUMAN LIFE. >> HE SAYS THERE IS NO SINGLE
>> HE SAYS THERE IS NO SINGLE ANSWER TO WHAT COMPASSION IS AND
ANSWER TO WHAT COMPASSION IS AND WHETHER IT LINES UP MORE WITH
WHETHER IT LINES UP MORE WITH SYMPATHY FOR EMPATHY.
SYMPATHY FOR EMPATHY. THE FACT IS, THAT COMPASSION IS
THE FACT IS, THAT COMPASSION IS NOT ONLY ABOUT FEELING IT, BUT
NOT ONLY ABOUT FEELING IT, BUT ABOUT PRACTICING IT.
ABOUT PRACTICING IT. AND THAT IS THE MESSAGE OF THIS
AND THAT IS THE MESSAGE OF THIS COMPASSION TRAINING.
COMPASSION TRAINING. >> MORE THAN EVER WE NEED TO
>> MORE THAN EVER WE NEED TO FIND A WAY TO EXPAND OUR
FIND A WAY TO EXPAND OUR EMOTIONAL HORIZONS SO THAT, OUR
EMOTIONAL HORIZONS SO THAT, OUR SENSE OF WHO OUR TRIBE IS IS
SENSE OF WHO OUR TRIBE IS IS EVERYBODY.
EVERYBODY. YOU LOOK AT THE WORLD.
YOU LOOK AT THE WORLD. PLACES HELD TOGETHER BY STRONG,
PLACES HELD TOGETHER BY STRONG, CENTRAL GOVERNMENTS.
CENTRAL GOVERNMENTS. DICTATORS.
DICTATORS. WITH REMOVAL OF THE FORCES YOU
WITH REMOVAL OF THE FORCES YOU ARE SEEING THIS UNBELIEVABLE
ARE SEEING THIS UNBELIEVABLE FRAGMENTING INTO SMALLER,
FRAGMENTING INTO SMALLER, SMALLER ETHNIC TRIBES.
SMALLER ETHNIC TRIBES. WARFARE.
WARFARE. WE ARE GOING BACKWARDS.
WE ARE GOING BACKWARDS. THE PROBLEM IS FOR THE MODERN
THE PROBLEM IS FOR THE MODERN WORLD TO SURVIVE.
WORLD TO SURVIVE. WE HAVE HOW TO BEGIN TO FIND NEW
WE HAVE HOW TO BEGIN TO FIND NEW WAYS TO PULL TOGETHER.
WAYS TO PULL TOGETHER. >> TO CONTINUE OUR DISCUSSION
>> TO CONTINUE OUR DISCUSSION ABOUT THE LINKS BETWEEN
ABOUT THE LINKS BETWEEN COMPASSION, WELL BEING AND
COMPASSION, WELL BEING AND SOCIETY.
SOCIETY. WE ARE JOINED BY LESLIE
WE ARE JOINED BY LESLIE LANGBURG, A CERTIFIED YOGA,
LANGBURG, A CERTIFIED YOGA, MEDITATION INSTRUCTOR.
MEDITATION INSTRUCTOR. LESLIE THANK YOU FOR JOINING US
LESLIE THANK YOU FOR JOINING US TODAY.
TODAY. >> THANK YOU FOR HAVING ME,
>> THANK YOU FOR HAVING ME, ALLEN.
ALLEN. GLUED BE HE
GLUED BE HE GLAD TO BE HERE.
GLAD TO BE HERE. >> WHAT IS COME SNAGS APASSION?
>> WHAT IS COME SNAGS APASSION? >> THE HEARTFELT WISH FOR
>> THE HEARTFELT WISH FOR ANOTHER TO BE HAPPY AND RELEASED
ANOTHER TO BE HAPPY AND RELEASED OF THEIR SUFFERING.
OF THEIR SUFFERING. IN WHATEVER SHAPE OR FORM THAT,
IN WHATEVER SHAPE OR FORM THAT, IS IN.
IS IN. >> LESLIE, WHY IS IT IMPORTANT
>> LESLIE, WHY IS IT IMPORTANT FOR HUMAN BEINGS TO BE
FOR HUMAN BEINGS TO BE COMPASSIONATE?
COMPASSIONATE? >> ALLEN, IF WE THINK ABOUT OUR
>> ALLEN, IF WE THINK ABOUT OUR SOCIETY AT LARGE.
SOCIETY AT LARGE. AND HOW WE CAN HELP TO CULTIVATE
AND HOW WE CAN HELP TO CULTIVATE A STRONGER SOCIETY.
A STRONGER SOCIETY. WHEN WE CARE ABOUT ANOTHER'S
WHEN WE CARE ABOUT ANOTHER'S WELL BEING.
WELL BEING. ALL OF US STAND TO BENEFIT IN A
ALL OF US STAND TO BENEFIT IN A MUCH GREATER WAY.
MUCH GREATER WAY. >> IS COMPASSION A NATURAL THING
>> IS COMPASSION A NATURAL THING OR SOMETHING THAT PEOPLE LEARN?
OR SOMETHING THAT PEOPLE LEARN? >> IT IS ACTUALLY BOTH.
>> IT IS ACTUALLY BOTH. COGNITIVELY BASED COMPASSION
COGNITIVELY BASED COMPASSION TRAINING REALLY BEGINS ON THE
TRAINING REALLY BEGINS ON THE PREDICATE THAT -- COMPASSION IS
PREDICATE THAT -- COMPASSION IS INBORN.
INBORN. BIOLOGICAL THAT WE HAVE FOR
BIOLOGICAL THAT WE HAVE FOR FOLKS THAT ARE CLOSEST TO US.
FOLKS THAT ARE CLOSEST TO US. IF WE THINK ABOUT THOSE THAT WE
IF WE THINK ABOUT THOSE THAT WE FEEL PRO TKTITECTIVE OF OR BY.
FEEL PRO TKTITECTIVE OF OR BY. FOLKS THAT WE FEEL AFFECTION
FOLKS THAT WE FEEL AFFECTION TOWARDS.
TOWARDS. COMPASSION COMES RELATIVELY
COMPASSION COMES RELATIVELY NATURALLY.
NATURALLY. WHERE IT DOESN'T COME IS
WHERE IT DOESN'T COME IS NATURALLY, IS WITH PEOPLE THAT
NATURALLY, IS WITH PEOPLE THAT WE DON'T KNOW.
WE DON'T KNOW. STRANGERS, OR PERHAPS, EVEN
STRANGERS, OR PERHAPS, EVEN PEOPLE WHO HAVE -- HAVE
PEOPLE WHO HAVE -- HAVE CHALLENGED US OR HARMED US IN
CHALLENGED US OR HARMED US IN SOME WAY.
SOME WAY. AND IN THAT REGARD, CBCT IS
AND IN THAT REGARD, CBCT IS REALLY POWERFUL TOOL TO
REALLY POWERFUL TOOL TO SYSTEMATICALLY HELP EXPAND AND
SYSTEMATICALLY HELP EXPAND AND WIDEN ONE'S NATURAL SENSE OF
WIDEN ONE'S NATURAL SENSE OF COMPASSION TO THOSE OUTSIDE OF
COMPASSION TO THOSE OUTSIDE OF THEIR GROUP.
THEIR GROUP. >> LOOKING AT BENEFITS OF
>> LOOKING AT BENEFITS OF COMPASSION.
COMPASSION. WHAT SORT OF PHYSIOLOGICAL
WHAT SORT OF PHYSIOLOGICAL BENEFITS AREABLEAB IN THE
BENEFITS AREABLEAB IN THE AREAS OF INFLAMMATION AND
AREAS OF INFLAMMATION AND DEPRESSION.
DEPRESSION. >> I WORK AT THE UNIVERSITY OF
>> I WORK AT THE UNIVERSITY OF ARIZONA.
ARIZONA. HE HAS DONE A COUPLE OF STUDIES.
HE HAS DONE A COUPLE OF STUDIES. WITH COLLEAGUES IN THIS AREA.
WITH COLLEAGUES IN THIS AREA. AND THEY FOUND THAT, MEDITATION
AND THEY FOUND THAT, MEDITATION PRACTITIONERS ENGAGED IN CBCT
PRACTITIONERS ENGAGED IN CBCT OVER TIME HAVE REDUCED LEVELS OF
OVER TIME HAVE REDUCED LEVELS OF DEPRESSION AND IN FACT HAVE
DEPRESSION AND IN FACT HAVE STRONGER IMMUNITY BECAUSE THEIR
STRONGER IMMUNITY BECAUSE THEIR CORTISOL LEVELS AND INFLAMMATORY
CORTISOL LEVELS AND INFLAMMATORY CAUSING HORMONES ARE SECRETED
CAUSING HORMONES ARE SECRETED LESS WHEN, WHEN THEY'RE
LESS WHEN, WHEN THEY'RE ENCOUNTERED WITH STRESSFUL
ENCOUNTERED WITH STRESSFUL SITUATIONS.
SITUATIONS. TO DESCRIBE THIS PROBABLY IN
TO DESCRIBE THIS PROBABLY IN MORE LAY PERSON TERMS.
MORE LAY PERSON TERMS. WHEN WE ARE -- MORE
WHEN WE ARE -- MORE COMPASSIONATE TOWARDS OTHERS,
COMPASSIONATE TOWARDS OTHERS, WHEN WE ARE ABLE TO, BEGIN TO
WHEN WE ARE ABLE TO, BEGIN TO EXTEND OR WIDEN THAT CIRCLE OF
EXTEND OR WIDEN THAT CIRCLE OF COMPASSION, WE, WE SEE PEOPLE
COMPASSION, WE, WE SEE PEOPLE AS -- BEING -- LIKE US.
AS -- BEING -- LIKE US. IN SOME WAY.
IN SOME WAY. WE HAVE THE COMMON DESIRE TO BE
WE HAVE THE COMMON DESIRE TO BE HAPPY HAND TO BE FRU AND TO BE
HAPPY HAND TO BE FRU AND TO BE SUFFERING.
SUFFERING. WHEN WE HAVE THAT EQUANIMITY, WE
WHEN WE HAVE THAT EQUANIMITY, WE ARE LESS ISOLATED.
ARE LESS ISOLATED. BETTER EQUIPPED AND CLOSER TO
BETTER EQUIPPED AND CLOSER TO SOCIETY TO OUR GROUP.
SOCIETY TO OUR GROUP. WE UNDERSTAND OUR
WE UNDERSTAND OUR INTERCONNECTION WITH THE LARGER
INTERCONNECTION WITH THE LARGER WORLD.
WORLD. WHICH CAN HELP US FEEL LESS
WHICH CAN HELP US FEEL LESS ISOLATED.
ISOLATED. [ INDISCERNIBLE ]
[ INDISCERNIBLE ] >> LESLIE, HOW CAN A PERSON
>> LESLIE, HOW CAN A PERSON BECOME MORE COMPASSIONATE?
BECOME MORE COMPASSIONATE? THROUGH THE PRACTICE OF CBCT.
THROUGH THE PRACTICE OF CBCT. THROUGH THIS, THIS MIND TRAINING
THROUGH THIS, THIS MIND TRAINING IF YOU WILL, ONE IS ABLE TO
IF YOU WILL, ONE IS ABLE TO BEGIN TO EXAMINE THEIR OWN --
BEGIN TO EXAMINE THEIR OWN -- THOUGHT PATTERNS.
THOUGHT PATTERNS. AND THEIR REACTIONS TO STRESSFUL
AND THEIR REACTIONS TO STRESSFUL SITUATIONS THAT COME UP.
SITUATIONS THAT COME UP. AND THROUGH -- THROUGH -- TAKE A
AND THROUGH -- THROUGH -- TAKE A CLOSER LOOK.
CLOSER LOOK. THEY UNDERSTAND THE NATURE OF
THEY UNDERSTAND THE NATURE OF THEIR SUFFERING.
THEIR SUFFERING. THROUGH SYSTEMATIC, MEDITATION
THROUGH SYSTEMATIC, MEDITATION PROCESS THATIS --
PROCESS THATIS -- INITIALLY OVER EIGHT WEEKS AND
INITIALLY OVER EIGHT WEEKS AND UNFOLD OVER A LIFETIME.
UNFOLD OVER A LIFETIME. FOLKS ARE ABLE TO BEGIN TO,
FOLKS ARE ABLE TO BEGIN TO, LITERALLY TRAIN THEIR MIND.
LITERALLY TRAIN THEIR MIND. >> IS THIS TRAINING, IS THIS THE
>> IS THIS TRAINING, IS THIS THE RELIGIOUS OR SECULAR SITUATION.
RELIGIOUS OR SECULAR SITUATION. >> SECULAR FORM OF MEDITATION.
>> SECULAR FORM OF MEDITATION. DERIVED FROM THE ANCIENT MIND
DERIVED FROM THE ANCIENT MIND TRAINING.
TRAINING. SECULARIZED FOR A WESTERN
SECULARIZED FOR A WESTERN AUDIENCE.
AUDIENCE. MOST MAJOR RELIGIONS HAVE AS ONE
MOST MAJOR RELIGIONS HAVE AS ONE OF THE CORE TENETS, COMPASSION
OF THE CORE TENETS, COMPASSION IS AN IMPORTANT ASPECT TO
IS AN IMPORTANT ASPECT TO CULTIVATE.
CULTIVATE. A REALLY WONDERFUL.
A REALLY WONDERFUL. EASY WAY TO SORT OF BUILD IN
EASY WAY TO SORT OF BUILD IN THAT MEDITATION PRACTICE.
THAT MEDITATION PRACTICE. THAT DOESN'T CONFLICT IN ANY WAY
THAT DOESN'T CONFLICT IN ANY WAY WITH ONE'S CURRENT BELIEF
WITH ONE'S CURRENT BELIEF SYSTEM.
SYSTEM. VERY BREFLY.
VERY BREFLY. HOW BIG IS THE DEMAND FOR
HOW BIG IS THE DEMAND FOR COMPASSION TRAINING.
COMPASSION TRAINING. >> IN TUCSON.
>> IN TUCSON. WE -- WE HAD 70 PERSONS ACTUALLY
WE -- WE HAD 70 PERSONS ACTUALLY ATTEND OUR RECENT IMMERSION IF
ATTEND OUR RECENT IMMERSION IF YOU, AS YOU KNOW.
YOU, AS YOU KNOW. WE HAVE A NUMBER OF
WE HAVE A NUMBER OF ORGANIZATIONS, GROUPS.
ORGANIZATIONS, GROUPS. THAT APPROACHED US HERE AT U OF
THAT APPROACHED US HERE AT U OF A.
A. INTERESTED IN WANTING TO -- TO
INTERESTED IN WANTING TO -- TO BE TRAINED.
BE TRAINED. IN THIS PARTICULAR MEDITATION
IN THIS PARTICULAR MEDITATION PRACTICE.
PRACTICE. IT IS GROWING.
IT IS GROWING. STEADILY.
STEADILY. IT EMERGED OUT OF ATLANTA.
IT EMERGED OUT OF ATLANTA. UNIVERSITY.
UNIVERSITY. AT EMORY.
AT EMORY. SORRY, IT EMERGED FROM ATLANTA
SORRY, IT EMERGED FROM ATLANTA EMORY UNIVERSITY.
EMORY UNIVERSITY. AND IT IS EXPANDING TO, TO OTHER
AND IT IS EXPANDING TO, TO OTHER STATES.
STATES. DEMAND IS GROWING.
DEMAND IS GROWING. LESLIE, THANK YOU FOR JOINING
LESLIE, THANK YOU FOR JOINING US.
US. >> THANK YOU SO MUCH FOR HAVING
>> THANK YOU SO MUCH FOR HAVING ME HERE, ALLEN.
ME HERE, ALLEN. IF IT'S BEEN A PLEASURE.
>>> EVERY YEAR, 3,000 CHILDREN ARE DIAGNOSED WITH
ARE DIAGNOSED WITH GASTROINTESTINAL DISORDER,
GASTROINTESTINAL DISORDER, INFLAMMATORY BOWEL DISEASE.
INFLAMMATORY BOWEL DISEASE. A TEAM OF DOCTORS AND SCIENTISTS
A TEAM OF DOCTORS AND SCIENTISTS AT THE STEEL CHILDREN'S RESEARCH
AT THE STEEL CHILDREN'S RESEARCH CENTER HAVE FOUND TWO PROTEINS
CENTER HAVE FOUND TWO PROTEINS THAT MAY HELP TO EXPLAIN WHY IBD
THAT MAY HELP TO EXPLAIN WHY IBD CAN PUT PEOPLE AT GREATER RISK
CAN PUT PEOPLE AT GREATER RISK OF DEVELOPING OSTEOPOROSIS
OF DEVELOPING OSTEOPOROSIS LATEREN LIFE.
LATEREN LIFE. ONE MEMBER OF THE RESEARCH TEAM,
ONE MEMBER OF THE RESEARCH TEAM, IS HERE TO EXPLAIN.
IS HERE TO EXPLAIN. THANK YOU SO MUCH FOR JOINING US
THANK YOU SO MUCH FOR JOINING US TODAY.
TODAY. >> THANK YOU.
>> THANK YOU. >> COULD YOU BRIEFLY EXPLAIN
>> COULD YOU BRIEFLY EXPLAIN WHAT ITS IBD?
WHAT ITS IBD? >> IBD IS -- DISORDERS.
>> IBD IS -- DISORDERS. THEY'RE COMPLEX.
THEY'RE COMPLEX. THEY'RE IMMUDRIVEN BY IMMUNE.
THEY'RE IMMUDRIVEN BY IMMUNE. AND THEY AFFECT 1.5 MILLION
AND THEY AFFECT 1.5 MILLION PEOPLE IN THE UNITED STATES WITH
PEOPLE IN THE UNITED STATES WITH THE DISORDERS.
THE DISORDERS. MANICALLY, CRONES DISEASE AND
MANICALLY, CRONES DISEASE AND ULCERITIS.
ULCERITIS. >> WHAT ARE THE SUFFERINGS?
>> WHAT ARE THE SUFFERINGS? >> INTESTINAL MANIFESTATION.
>> INTESTINAL MANIFESTATION. ABDOMINAL PAIN.
ABDOMINAL PAIN. DIARRHEA.
DIARRHEA. BLOOD IN THE STOOLS.
BLOOD IN THE STOOLS. MUCOUS IN THE STOOLS.
MUCOUS IN THE STOOLS. AND THEN JOINT PAIN.
AND THEN JOINT PAIN. 20% MAY PRESENT WITH ARTHRITIS.
20% MAY PRESENT WITH ARTHRITIS. AND LIVER DISEASE.
AND LIVER DISEASE. KIDNEY DISEASE.
KIDNEY DISEASE. BONE DISEASE.
BONE DISEASE. >> AND, FOR PEOPLE WHO ARE
>> AND, FOR PEOPLE WHO ARE SUFFERING FROM THE DISEASES.
SUFFERING FROM THE DISEASES. WHAT SORT OF TREATMENTS ARE
WHAT SORT OF TREATMENTS ARE AVAILABLE AT THIS TIME TO HELP
AVAILABLE AT THIS TIME TO HELP THEM OUT?
THEM OUT? >> FORTUNATELY, WE HAVE
>> FORTUNATELY, WE HAVE INCREDIBLE DRUGS NOWADAYS.
INCREDIBLE DRUGS NOWADAYS. TO TREAT PATIENTS WITH
TO TREAT PATIENTS WITH DISORDERS.
DISORDERS. THOSE START WITH AN ASPIRIN.
THOSE START WITH AN ASPIRIN. AND INFLAMMATION.
AND INFLAMMATION. MORE OVER, IF THE PATIENT HAS
MORE OVER, IF THE PATIENT HAS SIGNIFICANT DISORDER, WE CAN GO
SIGNIFICANT DISORDER, WE CAN GO TO SOMETHING PREDNIZONE AND
TO SOMETHING PREDNIZONE AND IMMU
IMMU IMMUNO MODULATORS.
IMMUNO MODULATORS. SUPPRESS YOUR IMMUNE SYSTEM.
SUPPRESS YOUR IMMUNE SYSTEM. FINALLY WE HAVE VERY STRONG
FINALLY WE HAVE VERY STRONG DRUGS.
DRUGS. >> SIR, YOU HAD A RECENT PAPER
>> SIR, YOU HAD A RECENT PAPER PUBLISHED IN "GASTROENTEROLOGY"
PUBLISHED IN "GASTROENTEROLOGY" COULD YOU TELL ME ABOUT THE
COULD YOU TELL ME ABOUT THE RESEARCH IN THE PAYER?
RESEARCH IN THE PAYER? >> SO, 50%, 60% OF PATIENTS WHO
>> SO, 50%, 60% OF PATIENTS WHO HAVE INFLAMMATORY BOWEL
HAVE INFLAMMATORY BOWEL DISORDERS.
DISORDERS. THEY HAVE BONE DISEASE.
THEY HAVE BONE DISEASE. MAIN LOW OSTEOPENIA.
MAIN LOW OSTEOPENIA. AND OSTEOPOROSIS.
AND OSTEOPOROSIS. AND HIGHER RISK OF DEVELOPING
AND HIGHER RISK OF DEVELOPING FRACTURES OF THE BONE.
FRACTURES OF THE BONE. THE CURRENT DOGMA IS TO TAKE
THE CURRENT DOGMA IS TO TAKE VITAMIN D.
VITAMIN D. HOWEVER OUR RESEARCH IN THIS
HOWEVER OUR RESEARCH IN THIS PAPER HAD SHOWN REALLY VITAMIN D
PAPER HAD SHOWN REALLY VITAMIN D CAN MAKE YOU WORSE IF YOU TAKE
CAN MAKE YOU WORSE IF YOU TAKE IT DURING ACTIVE FLAN MAGS.
IT DURING ACTIVE FLAN MAGS. L
L -- IT DURING ACTIVE
-- IT DURING ACTIVE INFLAMMATION.
INFLAMMATION. IT IS LOTS OF CALCIUM THROUGH
IT IS LOTS OF CALCIUM THROUGH YOUR KIDNEY AND ABILITY TO
YOUR KIDNEY AND ABILITY TO ABSORB CALCIUM IN THE GI TRACT.
ABSORB CALCIUM IN THE GI TRACT. THERE ARE CERTAIN TYPES THAT GET
THERE ARE CERTAIN TYPES THAT GET LOWER IN THE BONE.
LOWER IN THE BONE. >> HOW CAN WE COUNTERACT THAT,
>> HOW CAN WE COUNTERACT THAT, THAT LOSS OF CALCIUM.
THAT LOSS OF CALCIUM. IS THERE A METHODOLOGY AVAILABLE
IS THERE A METHODOLOGY AVAILABLE AT THIS TIME?
AT THIS TIME? >> WAIT TO TREAT THE PATIENTS.
>> WAIT TO TREAT THE PATIENTS. SHUT DOWN INFLAMMATION IN THE
SHUT DOWN INFLAMMATION IN THE GASTROINTESTINAL TRACT.
GASTROINTESTINAL TRACT. THE KIDNEYS START REABSORBING
THE KIDNEYS START REABSORBING THE CALCIUM.
THE CALCIUM. THE INTESTINES START REABSORBING
THE INTESTINES START REABSORBING THE CALCIUM.
THE CALCIUM. OUR RESEARCH HAS FOCUSED IN TWO
OUR RESEARCH HAS FOCUSED IN TWO PROTEINS.
PROTEINS. ONE PROTEIN, THIS PROTEIN IS
ONE PROTEIN, THIS PROTEIN IS PRESENT IN THREE AREAS OF THE
PRESENT IN THREE AREAS OF THE BODY WHICH REGULATE CALCIUM.
BODY WHICH REGULATE CALCIUM. ONE IS THE -- THE PART OF THE
ONE IS THE -- THE PART OF THE BRAIN.
BRAIN. AWE ONCE THIS GOES DOWN.
AWE ONCE THIS GOES DOWN. YOU ARE ABLE TO PUT THE CALCIUM
YOU ARE ABLE TO PUT THE CALCIUM TRANSPORT ON THE SURFACE TO
TRANSPORT ON THE SURFACE TO REABSORB CALCIUM.
REABSORB CALCIUM. SO THE MAIN PROBLEM IS TO SHUT
SO THE MAIN PROBLEM IS TO SHUT DOWN THE INFLAMMATION.
DOWN THE INFLAMMATION. THEN SUPPLEMENT WITH VITAMIN D,
THEN SUPPLEMENT WITH VITAMIN D, CALCIUM, PHOSPHATE.
CALCIUM, PHOSPHATE. THEY WILL DO VERY WELL.
THEY WILL DO VERY WELL. >> IF I FOR EXAMPLE HAD AN IBD.
>> IF I FOR EXAMPLE HAD AN IBD. HOW WOULD I KNOW IF I HAD THE
HOW WOULD I KNOW IF I HAD THE SITUATION WHERE I WAS LOSING THE
SITUATION WHERE I WAS LOSING THE CALCIUM?
CALCIUM? >> MEASURE HOW MUCH CALCIUM YOU
>> MEASURE HOW MUCH CALCIUM YOU ARE LOSING.
ARE LOSING. THE OTHER THING.
THE OTHER THING. DO THE SCAN.
DO THE SCAN. AND THAT WILL TELL US IF YOUR
AND THAT WILL TELL US IF YOUR BONES ARE THINNING OR NOT.
BONES ARE THINNING OR NOT. AND LOOKING AT IBD.
AND LOOKING AT IBD. IS THAT SOMETHING THAT STRIKES A
IS THAT SOMETHING THAT STRIKES A BROAD RANGE OF AGES.
BROAD RANGE OF AGES. OR FOCUSED ON ONE AGE GROUP.
OR FOCUSED ON ONE AGE GROUP. >> WE BELIEVE THAT -- IBD
>> WE BELIEVE THAT -- IBD STARTS.
STARTS. >> THE PINK WHERE YOU SEE IT.
>> THE PINK WHERE YOU SEE IT. SO IT IS CLEARLY -- IBD IS A
SO IT IS CLEARLY -- IBD IS A DISORDER IN THE AGE GROUP.
DISORDER IN THE AGE GROUP. HOWEVER, A LITTLE BIT LATER IN
HOWEVER, A LITTLE BIT LATER IN LIFE.
LIFE. WE BELIEVE IBD, YOU INHERIT THE
WE BELIEVE IBD, YOU INHERIT THE GENE, AND ENVIRONMENTALLY
GENE, AND ENVIRONMENTALLY DRIVEN.
DRIVEN. >> IS THIS SOMETHING VERY
>> IS THIS SOMETHING VERY BRIEFLY.
BRIEFLY. IS THIS SOMETHING THAT LASTS
IS THIS SOMETHING THAT LASTS THROUGHOUT ONE'S LIFE, SIR.
THROUGHOUT ONE'S LIFE, SIR. >> RELAPSES AND INTERMISSION.
>> RELAPSES AND INTERMISSION. AND OUR TASK AS DOCTORS IS TO
AND OUR TASK AS DOCTORS IS TO PUT YOU BACK IN REMISSION.
PUT YOU BACK IN REMISSION. BECAUSE THIS DISORDER, I WANT TO
BECAUSE THIS DISORDER, I WANT TO THANK YOU VERY MUCH FOR JOINING
THANK YOU VERY MUCH FOR JOINING US HERE TODAY.
US HERE TODAY. >> THANK YOU AGAIN FOR INVITING
>> THANK YOU AGAIN FOR INVITING ME TO BE HERE WITH YOU.
ME TO BE HERE WITH YOU. >> OUR NEXT GUEST HAS BEAUTIFUL
>> OUR NEXT GUEST HAS BEAUTIFUL IMAGES OF CANCER CELLS.
IMAGES OF CANCER CELLS. NOT MEANT TO BEAUTIFY CANCER,
NOT MEANT TO BEAUTIFY CANCER, RATHER HE PROVIDE A DIFFERENT
RATHER HE PROVIDE A DIFFERENT PERSPECTIVE.
PERSPECTIVE. ONE THAT MAY LEAD TO NEW
ONE THAT MAY LEAD TO NEW THERAPIES.
THERAPIES. PROFESSOR OF CELLULAR AND
PROFESSOR OF CELLULAR AND MOLECULAR MEDICINE AND
MOLECULAR MEDICINE AND UNIVERSITY OF ARIZONA CANCER
UNIVERSITY OF ARIZONA CANCER RESEARCHER, IS HERE TO EXPLAIN.
RESEARCHER, IS HERE TO EXPLAIN. GUS.
GUS. THANK YOU SO MUCH FOR JOINING US
THANK YOU SO MUCH FOR JOINING US TODAY.
TODAY. >> THANK YOU FOR INVITING ME.
>> THANK YOU FOR INVITING ME. >> COULD YOU EXPLAIN A LITTLE
>> COULD YOU EXPLAIN A LITTLE BIT ABOUT HOW YOU ACQUIRE IMAGES
BIT ABOUT HOW YOU ACQUIRE IMAGES OF CANCER CELLS IN YOUR
OF CANCER CELLS IN YOUR RESEARCH?
RESEARCH? >> IN THE LAB WE DO A LOT.
>> IN THE LAB WE DO A LOT. THIS IS ONE OF THE MAJOR THINGS
THIS IS ONE OF THE MAJOR THINGS THAT WE ARE GO CUSSED FOCUSED O.
THAT WE ARE GO CUSSED FOCUSED O. WE DO LIVE CELL IMAGING.
WE DO LIVE CELL IMAGING. >> WHAT ARE THE TOOLS.
>> WHAT ARE THE TOOLS. IN ADDITION TO MICROSCOPY, PHOTO
IN ADDITION TO MICROSCOPY, PHOTO SHOP WORK IS USED, INVOLVED?
SHOP WORK IS USED, INVOLVED? >> THIS IS PART OF LIKE THE
>> THIS IS PART OF LIKE THE IMAGE PROCESSION.
IMAGE PROCESSION. WHICH IS REQUIRED TWO STEPS.
WHICH IS REQUIRED TWO STEPS. FIRST TO ANALYZE THE IMAGES.
FIRST TO ANALYZE THE IMAGES. AND THIS IS USUALLY THE DATA.
AND THIS IS USUALLY THE DATA. AND THEN THE PRESENTATION OF THE
AND THEN THE PRESENTATION OF THE IMAGES.
IMAGES. WHICH IS TO MAKE THEM LOOK MORE
WHICH IS TO MAKE THEM LOOK MORE AND LOOK NICE.
AND LOOK NICE. YOU KNOW?
YOU KNOW? BUT OF COURSE, THIS IS -- WITHIN
BUT OF COURSE, THIS IS -- WITHIN THE CONTEXT OF THE SCIENCE.
THE CONTEXT OF THE SCIENCE. WE ARE NOT LIKE MANY MAKE THEM
WE ARE NOT LIKE MANY MAKE THEM LOOK DIFFERENT FROM THE ACTUAL
LOOK DIFFERENT FROM THE ACTUAL DATA.
DATA. WE USE PHOTO SHOP.
WE USE PHOTO SHOP. ALSO, AND BECAUSE OF A LOT OF
ALSO, AND BECAUSE OF A LOT OF WHAT WE DO IS FILMING THE CELLS
WHAT WE DO IS FILMING THE CELLS WHILE THEY'RE MOVING.
WHILE THEY'RE MOVING. FOR EXAMPLE.
FOR EXAMPLE. >> WHAT DO THE IMAGES OR FILMS
>> WHAT DO THE IMAGES OR FILMS TELL YOU ABOUT THE CANCER CELLS?
TELL YOU ABOUT THE CANCER CELLS? >> WE FOCUS A LOT ON CELL
>> WE FOCUS A LOT ON CELL MIGRATION.
MIGRATION. WHICH IS VERY IMPORTANT STEP AND
WHICH IS VERY IMPORTANT STEP AND CONCEPT IN CANCER BIOLOGY.
CONCEPT IN CANCER BIOLOGY. BECAUSE THIS IS AT THE HEART OF
BECAUSE THIS IS AT THE HEART OF METASTASIS, THE SPREADING OF
METASTASIS, THE SPREADING OF CANCER CELLS FROM
CANCER CELLS FROM TUMOR, SECONDARY ORGANS.
TUMOR, SECONDARY ORGANS. USUALLY THE CAUSE OF DEATH IN
USUALLY THE CAUSE OF DEATH IN CANCER.
CANCER. PATIENTS DON'T USUALLY DIE.
PATIENTS DON'T USUALLY DIE. THEY DON'T DIE FROM THE PRIMARY
THEY DON'T DIE FROM THE PRIMARY TUMORS.
TUMORS. BUT THEY DIE FROM THE
BUT THEY DIE FROM THE METASTASIS, ORGAN FAILURES AND
METASTASIS, ORGAN FAILURES AND ALL THAT.
ALL THAT. >> ACTIN IS LIKE THE BACKBONE OF
>> ACTIN IS LIKE THE BACKBONE OF THE CELL.
THE CELL. THE SKELETON OF THE CELL
THE SKELETON OF THE CELL BASICALLY.
BASICALLY. CELLS, MOST CELLS, CANCER CELLS
CELLS, MOST CELLS, CANCER CELLS ARE LIKE ACTIVITY REMODELING
ARE LIKE ACTIVITY REMODELING THEIR ACTIN ON THE GO IN ORDER
THEIR ACTIN ON THE GO IN ORDER TO CHANGE THEIR SHAPE, BEHAVIOR
TO CHANGE THEIR SHAPE, BEHAVIOR AND THEIR INTERACTIONS WITH THE
AND THEIR INTERACTIONS WITH THE MICROENVIRONMENT.
MICROENVIRONMENT. AND THIS IS HOW THEY -- AND THEN
AND THIS IS HOW THEY -- AND THEN TRAVEL.
TRAVEL. >> GUS, IS YOUR IMAGING
>> GUS, IS YOUR IMAGING TECHNIQUE ABLE TO ACTUALLY SHOW
TECHNIQUE ABLE TO ACTUALLY SHOW THE CANCER, THE INVASIVE CANCER
THE CANCER, THE INVASIVE CANCER AS IT MOVES IN AND MULTIPLIES
AS IT MOVES IN AND MULTIPLIES THEN?
THEN? >> WE DO A LOT OF SINGLE CELL
>> WE DO A LOT OF SINGLE CELL BIOLOGY.
BIOLOGY. SO WE TAKE CANCER CELLS.
SO WE TAKE CANCER CELLS. WHICH IS CELLS.
WHICH IS CELLS. AND WE IMAGE THEM AS INDIVIDUAL
AND WE IMAGE THEM AS INDIVIDUAL CELLS.
CELLS. TO STUDY THEIR BEHAVIOR CLOSELY.
TO STUDY THEIR BEHAVIOR CLOSELY. OTHER LABS AS WELL.
OTHER LABS AS WELL. THEY DO IMAGING.
THEY DO IMAGING. THE IMAGE, IN MY CELL, OR
THE IMAGE, IN MY CELL, OR EXAMPLE, EXPERIMENTAL MODELS.
EXAMPLE, EXPERIMENTAL MODELS. WE DO 3-D IMAGING.
WE DO 3-D IMAGING. THERE ARE MULTIPLE CONTEXT WHERE
THERE ARE MULTIPLE CONTEXT WHERE WE IMAGE CANCER CELLS.
WE IMAGE CANCER CELLS. AND LOOK AT THEIR BEHAVIOR.
AND LOOK AT THEIR BEHAVIOR. >> WE ARE TALKING ABOUT --
>> WE ARE TALKING ABOUT -- VISUALLY MANIPULATING THE, THE
VISUALLY MANIPULATING THE, THE CELL IMAGES.
CELL IMAGES. WHAT EXACTLY ARE YOU
WHAT EXACTLY ARE YOU MANIPULATING IN, IN THOSE,
MANIPULATING IN, IN THOSE, IMAGES?
IMAGES? >> WE ARE NOT MANIPULATING THE
>> WE ARE NOT MANIPULATING THE DATA.
DATA. IT IS MORE LIKE A HOBBY,
IT IS MORE LIKE A HOBBY, SCIENCE.
SCIENCE. I LIKE GRAPHIC ARTS.
I LIKE GRAPHIC ARTS. AND I LIKE TO -- TO -- CREATE
AND I LIKE TO -- TO -- CREATE CARTOONS.
CARTOONS. BASICALLY.
BASICALLY. OF THE CELLS.
OF THE CELLS. AND THIS FOR ME IS IMPORTANT
AND THIS FOR ME IS IMPORTANT BECAUSE THE WORK WE DO IS
BECAUSE THE WORK WE DO IS VISUAL.
VISUAL. IT IS BASED ON MICROSCOPY.
IT IS BASED ON MICROSCOPY. THESE ARE COMPLEX CONCEPTS.
THESE ARE COMPLEX CONCEPTS. IT IS VERY IMPORTANT TO SIMPLIFY
IT IS VERY IMPORTANT TO SIMPLIFY THEM IN A GRAPHIC, LIKE A
THEM IN A GRAPHIC, LIKE A CARTOON FOR EXAMPLE.
CARTOON FOR EXAMPLE. THIS IS MOSTLY THE PART THAT --
THIS IS MOSTLY THE PART THAT -- THAT IS MORE EMERGING, MERGING
THAT IS MORE EMERGING, MERGING INTO THE ARTS BASICALLY MORE
INTO THE ARTS BASICALLY MORE THAN THE SCIENCE.
THAN THE SCIENCE. >> HOW IS YOUR RESEARCH BEING --
>> HOW IS YOUR RESEARCH BEING -- USED TO DEVELOP POSSIBLE CURES
USED TO DEVELOP POSSIBLE CURES OR TREATMENTS FOR CANCERS.
OR TREATMENTS FOR CANCERS. >> SO THIS IS MORE -- BECAUSE OF
>> SO THIS IS MORE -- BECAUSE OF THE FOCUS THAT WE ARE, YOU KNOW,
THE FOCUS THAT WE ARE, YOU KNOW, THE QUESTION THAT WE ARE AFTER
THE QUESTION THAT WE ARE AFTER IS HOW THE CELLS MOVE.
IS HOW THE CELLS MOVE. AND, WE ARE ABLE TO FIGURE THAT
AND, WE ARE ABLE TO FIGURE THAT OUT, WE ARE ABLE TO STOP THE
OUT, WE ARE ABLE TO STOP THE CELLS.
CELLS. OR AT LEAST TO IDENTIFY THE
OR AT LEAST TO IDENTIFY THE CELLS THAT ARE PRONE TO
CELLS THAT ARE PRONE TO MIGRATING AND MAN IMPORTANT STE.
MIGRATING AND MAN IMPORTANT STE. AND IT WOULD BE A VERY
AND IT WOULD BE A VERY IMPORTANT, TO HAVE, VERY GOOD
IMPORTANT, TO HAVE, VERY GOOD OUTCOME FOR PATIENTS EVENTUALLY.
OUTCOME FOR PATIENTS EVENTUALLY. >> WE HAVE, ABOUT 45 SECOND
>> WE HAVE, ABOUT 45 SECOND LEFT.
LEFT. WHAT DO YOU HOPE THAT YOUR WORK
WHAT DO YOU HOPE THAT YOUR WORK WILL ACHIEVE?
WILL ACHIEVE? ARE YOU LOOKING FOR LIKE A CURE
ARE YOU LOOKING FOR LIKE A CURE FOR CANCER HERE?
FOR CANCER HERE? >> WELL THIS IS NOT REALISTIC.
>> WELL THIS IS NOT REALISTIC. BUT, WHAT, WE HOPE TO ACHIEVE
BUT, WHAT, WE HOPE TO ACHIEVE REALISTICALLY IS TO, TO BE ABLE
REALISTICALLY IS TO, TO BE ABLE TO UNDERSTAND HOW CANCER MOVES.
TO UNDERSTAND HOW CANCER MOVES. AND POSSIBLY, TEST DRUGS OR
AND POSSIBLY, TEST DRUGS OR DEVELOP DRUGS THAT WILL, WILL
DEVELOP DRUGS THAT WILL, WILL BLOCK THE MIGRATORY STEP OF
BLOCK THE MIGRATORY STEP OF CANCER CELLS AND COUPLED WITH
CANCER CELLS AND COUPLED WITH CHEMOTHERAPY THIS WOULD
CHEMOTHERAPY THIS WOULD REPRESENT AN IMPORTANT TREATMENT
REPRESENT AN IMPORTANT TREATMENT STRATEGY IN THE FUTURE.
STRATEGY IN THE FUTURE. >> GUS, IS THIS RESEARCH UNIQUE
>> GUS, IS THIS RESEARCH UNIQUE TO ARIZONA CANCER CENTER HERE AT
TO ARIZONA CANCER CENTER HERE AT U OF A?
U OF A? >> I HAVE A FEW COLLEAGUES.
>> I HAVE A FEW COLLEAGUES. WE WORK TOGETHER.
WE WORK TOGETHER. WE COLLABORATE.
WE COLLABORATE. WITH THE CANCER CENTER, I HAVE A
WITH THE CANCER CENTER, I HAVE A COUPLE OF COLLEAGUES ALSO.
COUPLE OF COLLEAGUES ALSO. WE DO, COMPLEMENTARY WORK, LET'S
WE DO, COMPLEMENTARY WORK, LET'S SAY THEY LOOK AT DIFFERENT
SAY THEY LOOK AT DIFFERENT ASPECTS OF CELL MIGRATION AND
ASPECTS OF CELL MIGRATION AND BEHAVIOR.
BEHAVIOR. >> GUS, THANK YOU FOR JOINING US
>> GUS, THANK YOU FOR JOINING US TODAY.
TODAY. >> THANK YOU SO MUCH FOR
>> THANK YOU SO MUCH FOR INVITING ME.